The FDA has cleared the single-source Nano.ARC machine, which will be used in tomosynthesis applications (checking for breast cancer). It’s a big step for the company which takes away some risk for investors in the company. This is a major milestone for Nano-X but much work remains and there are still manufacturing and distribution hurdles to be cleared. We’ll also be talking Nike and its efforts to go direct-to-consumer which has shut out some major retailers.

Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year.

Start your journey toward's financial independence: https://www.7investing.com/subscribe

Stop by our website to level-up your investing education:  https://www.7investing.com

Follow us on Social Media

► https://www.facebook.com/7investing/

► https://twitter.com/7investing

► https://instagram.com/7investing